Toronto, Ontario and Rionegro, Colombia–(Newsfile Corp. – July 11, 2023) – PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) (“PharmaCielo” or the “Company”), the Canadian parent of Colombia’s...
PharmaCielo is actively working with more than 24 customers in 15 countries globally, with a focus on psychoactive APIs and dried flower. The Company recently made...
The Company has products in various stages of testing and sales with more than 40 customers in 11 countries, with continued growth expected for the year....
Represents PharmaCielo’s first shipment to South Africa, which has well-established export networks in the UK and Australia, and other potential markets, globally. Toronto, Ontario and Rionegro,...
During 2022, PharmaCielo made shipments to 23 clients in 9 countries, with continued growth expected for 2023. The Company’s measured investments in revenue-generating sales channels resulted...
Will bring unique high-THC Colombian strains owned by PharmaCielo to Europe for the first time. Combines PharmaCielo’s expertise in producing premium medicinal cannabis products, with CANNPRISMA’s...